Osteoporosis and Bone cancer


Both generalized and local bone loss are significantly more common in cancer patients than in the general population, regardless of the kind of disease, as determined by bone mineral density (BMD) testing. Numerous, connected causes contribute to bone loss in people with cancer. With relatively few studies on other cancers, the majority of current research has been on bone loss in patients with breast and prostate cancer. Although few studies have been powered sufficiently to include fractures as primary endpoints, and patients are frequently neither identified nor treated in accordance with published guidelines, anti-resorptive therapies have consistently shown to be effective in limiting bone loss in cancer patients.